Abstract
Background
Severe acute respiratory syndrome coronavirus 2 causes acute myocardial damage and arrhythmia in coronavirus disease 2019 (COVID‐19) patients. Studying the changes of electrocardiogram is of great significance for the diagnosis of patients with COVID‐19.
Methods
A retrospective analysis method was adopted to compare the electrocardiogram changes between COVID‐19 critically severe and severe patients. Univariate and multivariate logistic regression were used to analyze the correlation of the levels of serum indexes and past medical history with ST‐T changes and atrial fibrillation. And the correlation of ECG parameters with in‐hospital death and ventilator use were investigated by using the same methods.
Results
The incidence of male, stroke, elevated cardiac troponin I (cTnI), N‐terminal of the prohormone brain natriuretic peptide (NT‐proBNP), d‐dimer, high‐sensitivity C‐reactive protein (hs‐CRP), hyperkalemia, and hypocalcemia in the critically ill patients was higher than that in severe patients. There were differences in ST‐T changes, sinus tachycardia, atrial fibrillation, and atrial tachycardia between the two groups. Multivariate logistic regression analysis showed that elevated cTnI and NT‐proBNP were the independent risk factors of ST‐T changes. Elevated NT‐proBNP and age were the independent risk factors of atrial fibrillation. Sinus tachycardia and atrial fibrillation were the independent risk factors of in‐hospital death and ventilator use.
Conclusion
ST‐T changes, sinus tachycardia, and atrial fibrillation are with great significance in the diagnosis of the severity, myocardia injury, and cardiac insufficiency of COVID‐19 patients. Sinus tachycardia and atrial fibrillation could be used as independent variables predicting in‐hospital death and ventilator use.
Keywords: COVID‐19, electrocardiogram, myocardial injury, ST‐T changes
1. INTRODUCTION
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), also known as the new coronavirus, infects humans and causes coronavirus disease 2019 (COVID‐19), a highly infectious disease. Currently, SARS‐CoV‐2 has caused a worldwide epidemic with more than ten million of infections, and the cumulative number of infections continues to rise (World Health Organization, 2020). In addition to causing severe damage to the respiratory system, SARS‐CoV‐2 also causes acute myocardial damage, resulting in arrhythmia (Dawei et al., 2020; Elissa et al., 2020; Hongde, Fenglian, Xin, & Yuan, 2020). It has been suggested that myocardial damage is an important clinical feature of COVID‐19 critically ill patients (Chen et al., 2020). As one of the most used clinical examination methods, electrocardiogram (ECG) is an irreplaceable important technique for recording cardiac electrical activity. It is of great significance to study the changes of electrocardiogram in patients with COVID‐19. Therefore, to understand the ECG features of distinct types of COVID‐19 patients, we retrospectively analyzed the electrocardiograms of 408 critically ill and noncritical COVID‐19 patients and dissected the relationship between abnormal changes in ECG and myocardial injury. Our study provides an electrocardiographic basis for the early diagnosis and treatment of COVID‐19‐induced myocardial injury.
2. METHODS
2.1. Inspection objects
COVID‐19 critically ill and noncritical patients admitted to the Optics Valley Campus and the Sino‐French New City Campus of Tongji Hospital, an Affiliated hospital of Tongji Medical College of Huazhong University of Science and Technology, from January 27, 2020, to March 21, 2020. The diagnosis and typing criteria were based on the World Health Organization interim guidance (World Health Organization, 2020). The study was approved by the Medical Ethics Committee of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology (Approval Number: TJ‐C20200140). This study is a retrospective study without a need for signed informed consent.
2.2. Examination method
The twelve‐channel conventional ECG collected at the first time after the patients admitted to the hospital was used and divided into normal and abnormal based on the ECG diagnosis. ECG diagnosis was performed according to the 2009 ACC, AHA, HRS ECG standardization and analysis guidelines (Borys et al., 2009; Galen et al., 2009; Jay et al., 2007; Paul et al., 2007; Pentti et al., 2009; William et al., 2009). The exclusion criteria of ST‐T changes were nonspecific ST‐T changes caused by ventricular premature beats, bundle branch block, ventricular pre‐excitation, and pacemaker implantation.
2.3. Laboratory examination
After the patients were admitted to the hospital, their myocardial troponin I (cTnI), N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP), d‐dimer, serum calclum, and high‐sensitivity C‐reactive protein (hs‐CRP) levels were examined. According to the clinical laboratory manual of Tongji Hospital and reagent instructions, an elevated cTnI was defined as a cTnI level that exceeds the upper limit of the cTnI levels of 99th percentile of the population; the normal reference intervals of NT‐proBNP are as follows: 5.0–97.3 ng/L for 18–44 years old, 5.0–121.0 ng/L for 45–54 years old, 5.0–198.0 ng/L for 55–64 years old, 5.0–285.0 ng/L for 65–74 years old, and 5.0–526.0 ng/L for ≥ 75 years old.
2.4. Statistical analysis
Statistical analysis was performed using SPSS21.0 software. For statistical comparison of two groups, measured data conforming to normal distribution were analyzed using independent sample t test, while count data were analyzed using chi‐square test. If the minimum expected value is <5, Fisher's exact test was used. Univariate and multivariate logistic regression were used to analyze the risk factors of ST‐T changes in ECG of COVID‐19 patients. A p value <.05 (p < .05) indicates that the differences between groups are statistically significant.
3. RESULTS
3.1. Basic data of patients
319 cases, consisting of 152 males and 167 females aged from 22 to 92 years, were enrolled in this study. The average age of the critically severe type was greater than that of severe type (p < .05), and the proportion of males in the critically severe type was higher than that in the other type (p < .05). The proportion of stroke in the critically ill group was significantly higher than that in the severe group (p < .05). The incidence of elevated cTnI (p < .001), NT‐proBNP (p < .001), d‐dimer (p < .001), and hs‐CRP (p < .001) levels and hypocalcemia (p = .002) in the critically ill patients was higher than that of patients with severe type (Table 1).
Table 1.
Subject characteristics
| Subject | Overall | Critically sever type | Sever type | t/χ 2 | p value |
|---|---|---|---|---|---|
| Age (years) | 64.97 ± 13.15 | 67.23 ± 14.43 | 63.98 ± 12.46 | 2.040 | .042 |
| Male, n (%) | 152 (47.6) | 69 (71.1) | 83 (37.4) | 30.819 | <.001 |
| Medical history, n (%) | |||||
| Hypertension, n (%) | 139 (43.6) | 49 (50.5) | 90 (40.5) | 2.732 | .098 |
| Coronary heart disease, n (%) | 47 (14.7) | 19 (19.6) | 28 (12.6) | 2.614 | .106 |
| PCI or CABG, n (%) | 10 (3.1) | 6 (6.2) | 4 (1.8) | / | .073 |
| Diabetes mellitus, n (%) | 73 (22.9) | 26 (26.8) | 47 (21.2) | 1.214 | .271 |
| Stroke, n (%) | 13 (4.1) | 8 (8.2) | 5 (2.3) | / | .026 |
| Elevated cTnI, n (%) | 74 (23.2) | 44 (45.4) | 30 (13.5) | 38.429 | <.001 |
| Elevated NT‐proBNP, n (%) | 152 (47.6) | 75 (77.3) | 77 (34.7) | 49.191 | <.001 |
| Elevated d‐dimer, n (%) | 199 (62.4) | 44 (45.4) | 155 (69.8) | 17.209 | <.001 |
| Hypocalcemia, n (%) | 243 (76.2) | 85 (87.6) | 158 (71.2) | 10.075 | .002 |
| Elevated hs‐CRP, n (%) | 291 (91.2) | 97 (100) | 194 (87.4) | / | <.001 |
Abbreviations: CABG, Coronary Artery Bypass Grafting; cTnI, cardiac troponin I; hs‐CRP, high‐sensitivity C‐reactive protein; NT‐proBNP, N‐terminal of the prohormone brain natriuretic peptide; PCI, Percutaneous Transluminal Coronary Intervention.
3.2. ECG changes in critically severe and severe types
118 cases (37.0%) had normal ECG, and 201 (63%) had abnormal ECG. Among the critically ill patients (97 cases), 15 (15%) cases had normal ECG and 82(86.0%) cases had abnormal ECG, and the highest proportion of abnormal ECG was ST‐T changes (47 cases, 48.5%), followed by sinus tachycardia (29 cases, 29.9%), atrial arrhythmia (13 cases, 13.4%), and right bundle branch block (12 cases, 12.4%). Among the patients with severe type (222 cases), 103 cases (46.4%) had normal ECG, and 119 cases (53.6%) had abnormal ECG, including ST‐T changes (57 cases, 25.7%), right bundle branch block (19 cases, 8.6%), and sinus bradycardia (28 cases, 9.5%) (Table 2). There was statistical significance on ST‐T change (p < .001), sinus tachycardia (p < .001), atrial fibrillation (p = .001), atrial tachycardia (p = .008), and abnormal Q‐wave and poor R‐wave progression (p = .001) between critical severe and severe types (Table 2).
Table 2.
ECG changes in critically sever type and sever type
| Overall, n (%) | Critically sever type, n (%) | Sever type, n (%) | χ 2 | p value | |
|---|---|---|---|---|---|
| Normal ECG | 118 (37.0) | 15 (15.5) | 103 (46.4) | 27.712 | <.001 |
| Abnormal ECG | 201 (63.0) | 82 (84.5) | 119 (53.6) | 27.712 | <.001 |
| ST‐T change | 104 (32.6) | 47 (48.5) | 57 (25.7) | 15.939 | <.001 |
| Sinus tachycardia | 40 (12.5) | 29 (29.9) | 11 (5.0) | 38.292 | <.001 |
| Atrial arrhythmia | |||||
| Atrial fibrillation | 20 (6.6) | 12 (13.4) | 8 (3.6) | 10.539 | .001 |
| Atrial flutter | 4 (1.3) | 3 (3.1) | 1 (0.5) | — | .085 |
| Atrial tachycardia | 4 (1.3) | 4 (4.1) | 0 | — | .008 |
| Atrial premature beats | 15 (4.7) | 8 (8.2) | 7 (3.2) | 5.083 | .080 |
| Bradyarrhythmia | |||||
| Sinus bradycardia | 19 (6.0) | 4 (4.1) | 15 (6.8) | 0.836 | .361 |
| First degree AVB | 11 (3.4) | 3 (3.1) | 8 (3.6） | — | 1.000 |
| Second degree AVB | 2 (0.6) | 0 | 2 (0.9) | — | 1.000 |
| Bundle branch block | |||||
| Right bundle branch block | 31 (9.7) | 12 (12.4) | 19 (8.6) | 1.118 | .290 |
| Left bundle branch block | 3 (0.9) | 2 (2.1) | 1 (0.5) | — | .220 |
| Left anterior fascicular block | 9 (2.8) | 5 (5.2) | 4 (1.8) | 6.140 | .137 |
| Ventricular premature beats | 10 (3.1) | 4 (4.1) | 6 (2.7) | 2.988 | .499 |
| Low voltage | 5 (1.6) | 3 (3.1) | 2 (0.9) | — | .180 |
| Abnormal Q‐wave and poor R‐wave progression | 18 (5.6) | 12 (12.4) | 6 (2.7) | 11.852 | .001 |
| Others | |||||
| Left ventricular high voltage or hypertrophy | 21 (6.6) | 7 (7.2) | 14 (6.3) | 0.091 | .763 |
| Abnormal U wave | 6 (1.9) | 2 (2.1) | 4 (1.8) | — | 1.000 |
| Long QT interval | 4 (1.3) | 1 (1.0) | 3 (1.4) | — | 1.000 |
Abbreviations: AVB, atrioventricular block; ECG, electrocardiograph.
3.3. Univariate and multivariate logistic regression analysis of ST‐T changes in ECG of COVID‐19 patients
Univariate logistic regression analysis showed that elevated cTnI (OR = 4.345, 95% CI 2.498–7.558, p < .001), elevated NT‐proBNP (OR = 3.559, 95% CI 2.166–5.848, p < .001), hyperkalemia (OR = 2.280, 95% CI 1.229–4.230, p = .009), elevated hs‐CRP (OR = 4.430, 95% CI 1.306–15.029, p = .017), hepertension (OR = 1.855, 95% CI 1.156–2.978, p = .010), stroke (OR = 3.500, 95% CI 1.116–10.978, p = .032), critically ill (OR = 2.721, 95% CI 1.652–4.483, p < .001), and age (OR = 1.039, 95% CI 1.018–1.060, p < .001) were significantly corrected with ST‐T abnormal changes. Multivariate logistic regression analysis showed that elevated cTnI (OR = 2.164, 95% CI 1.135–4.124, p = .019) and NT‐proBNP (OR = 1.939, 95% CI 1.077–3.488, p = .027) levels were the independent risk factors of ST‐T changes in ECG (Table 3).
Table 3.
Univariate and multivariate logistic regression analysis of ST‐T changes in ECG of COVID‐19 patients
| Factors | Univariate logistic regression analysis | p值 | Multivariate logistic regression analysis | p值 |
|---|---|---|---|---|
| OR值 (95% CI) | OR值 (95% CI) | |||
| Elevated cTnI | 4.345 (2.498, 7.558) | <.001 | 2.322 (1.230, 4.384) | .009 |
| Elevated NT‐proBNP | 3.559 (2.166, 5.848) | <.001 | 1.937 (1.080, 3.475) | .027 |
| Elevated d‐dimer | 1.759 (0.962, 3.216) | .066 | ||
| Hypocalcemia | 0.780 (0.455, 1.338) | .367 | ||
| Elevated hs‐CRP | 4.430 (1.306, 15.029) | .017 | 1.679 (0.457, 6.167) | .435 |
| Hypertension | 1.855 (1.156, 2.978) | .010 | 1.468 (0.872, 2.470) | .149 |
| CHD | 1.305 (0.678, 2.510) | .425 | ||
| Diabetes | 1.072 (0.618, 1.860) | .805 | ||
| Stroke | 3.500 (1.116, 10.978) | .032 | 1.812 (0.522, 6.290) | .349 |
| Male | 1.150 (0.720, 1.837) | .559 | ||
| Critically ill | 2.721 (1.652, 4.483) | <.001 | 1.404 (0.784, 2.515) | .253 |
| Age | 1.039 (1.018, 1.060) | <.001 | 1.019 (0.997, 1.042) | .084 |
Abbreviations: CHD, coronary heart disease; cTnI, cardiac troponin I; ECG:electrocardiogram, hs‐CRP, high‐sensitivity C‐reactive protein; NT‐proBNP, N‐terminal of the prohormone brain natriuretic peptide.
3.4. Univariate and multivariate logistic regression analysis of atrial fibrillation in ECG of COVID‐19 patients
Univariate logistic regression analysis showed that elevated cTnI (OR = 2.688, 95% CI 1.085–6.659, p = .033), elevated NT‐proBNP (OR = 25.152, 95% CI 3.332–189.853, p = .002), stroke (OR = 4.800, 95% CI 1.213–18.990, p = .025), critically ill (OR = 4.140, 95% CI 1.656–10.48, p = .002), and age (OR = 1.133, 95% CI 1.071–1.198, p < .001) were significantly corrected with atrial fibrillation. Multivariate logistic regression analysis showed that elevated NT‐proBNP (OR = 13.280, 95% CI 1.900–108.287, p = .016) and age (OR = 1.103, 95% CI 1.043–1.166, p = .001) were the independent risk factors of atrial fibrillation in ECG (Table 4).
Table 4.
Univariate and multivariate logistic regression analysis of atrial fibrillation in ECG of COVID‐19 patients
| Factors | Univariate logistic regression analysis | p值 | Multivariate logistic regression analysis | p值 |
|---|---|---|---|---|
| OR值 (95% CI) | OR值 (95% CI) | |||
| Elevated cTnI | 2.688 (1.085, 6.659) | .033 | 0.597 (0.206, 1.728) | .342 |
| Elevated NT‐proBNP | 25.152 (3.332, 189.853) | .002 | 13.280 (1.9, 108.287) | .016 |
| Hypertension | 1.795 (0.734, 4.390) | .200 | ||
| CHD | 1.045 (0.295, 3.705) | .946 | ||
| Diabetes | 1.037 (0.367, 2.933) | .945 | ||
| Stroke | 4.800 (1.213, 18.990) | .025 | 2.435 (0.495, 11.972) | .273 |
| Male | 0.999 (0.412, 2.422) | .998 | ||
| Critically ill | 4.140 (1.656, 10.348) | .002 | 2.110 (0.738, 6.031) | .164 |
| Age | 1.133 (1.071, 1.198) | <.001 | 1.103 (1.043, 1.166) | .001 |
Abbreviations: CHD, coronary heart disease; cTnI, cardiac troponin I; NT‐proBNP, N‐terminal of the prohormone brain natriuretic peptide.
3.5. Univariate and multivariate logistic regression analysis of ECG parameters with in‐hospital death and ventilator use of COVID‐19 patients
Univariate logistic regression analysis showed that ST‐T changes (OR = 2.518, 95% CI 1.357–4.674, p = .003), sinus tachycardia (OR = 6.545, 95% CI 3.166–13.531, p < .001), atrial fibrillation (OR = 3.857, 95% CI 1.506–9.879, p = .005), and abnormal Q‐wave and poor R‐wave progression (OR = 3.000, 95% CI 1.069–8.418, p = .037) were related to in‐hospital death. Sinus tachycardia (OR = 4.804, 95% CI 2.322–9.941, p < .001) and atrial fibrillation (OR = 4.701, 95% CI 1.864–11.856, p = .001) were related to the need for ventilator. Multivariate logistic regression analyses showed that sinus tachycardia (OR = 7.932, 95% CI 3.660–17.189, p < .001) (OR = 6.213, 95% CI 2.920–13.222, p < .001) and atrial fibrillation (OR = 5.338, 95% CI 1.882–15.142, p = .002) (OR = 6.990, 95% CI 2.683–18.213, p < .001) were the independent risk factors of both the two outcome (Table 5).
Table 5.
Univariate and multivariate logistic regression analysis of in‐hospital death of COVID‐19 patients
| Factors | Univariate logistic regression analysis | p值 | Multivariate logistic regression analysis | p值 |
|---|---|---|---|---|
| OR值 (95% CI) | OR值 (95% CI) | |||
| ST‐T changes | 2.518 (1.357, 4.674) | .003 | 1.748 (0.861, 3.549) | .122 |
| Sinus tachycardia | 6.545 (3.166, 13.531) | <.001 | 7.932 (3.660, 17.189) | <.001 |
| Atrial fibrillation | 3.857 (1.506, 9.879) | .005 | 5.338 (1.882, 15.142) | .002 |
| Atrial tachycardia | 3.787 (0.616, 23.238) | .151 | ||
| Atrial flutter | 0.000 | .999 | ||
| Atrial premature beats | 2.955 (0.964, 9.056) | .058 | ||
| Sinus bradycardia | 0.292 (0.038, 2.237) | .236 | ||
| First degree AVB | 1.234 (0.258, 5.892) | .792 | ||
| Second degree AVB | 0.000 | .999 | ||
| RBBB | 1.309 (0.509, 3.369) | .576 | ||
| Ventricular premature beats | 1.599 (0.322, 7.933) | .566 | ||
| Abnormal Q‐wave and poor R‐wave progression | 3.000 (1.069, 8.418) | .037 | 2.746 (0.830, 9.083) | .098 |
| Left ventricular high voltage or hypertrophy | 0.000 | .998 |
Abbreviation: AVB, atrioventricular block.
4. DISCUSSION
COVID‐19 mainly causes lung injury, but it can also affect multiple organs throughout the body, including the heart, kidneys, and liver. A recent study shows that all populations are susceptible, but males, elders, and people with a history of hypertension and coronary heart disease are more likely to develop critical illness (Chen et al., 2020). Our study found that the average age of patients in the COVID‐19 critically ill group was higher than that in the severe group and that the proportion of males in the critically ill group was significantly higher than that of severe type. Moreover, many critically ill patients generally had underlying diseases such as hypertension and coronary heart disease, but only the proportion of stroke in the two groups was significantly different (Table 6).
Table 6.
Univariate and multivariate logistic regression analysis of ventilator use of COVID‐19 patients
| Factors | Univariate logistic regression analysis | p值 | Multivariate logistic regression analysis | p值 |
|---|---|---|---|---|
| OR值 (95% CI) | OR值 (95% CI) | |||
| ST‐T changes | 1.623 (0.874, 3.012) | .125 | ||
| Sinus tachycardia | 4.804 (2.322, 9.941) | <.001 | 6.213 (2.920, 13.222) | <.001 |
| Atrial fibrillation | 4.701 (1.864, 11.856) | .001 | 6.990 (2.683, 18.213) | <.001 |
| Atrial tachycardia | 0.000 | .999 | ||
| Atrial flutter | 5.562 (0.765, 40.445) | .090 | ||
| Atrial premature beats | 2.878 (0.940, 8.813) | .064 | ||
| Sinus bradycardia | 1.009 (0.283, 3.601) | .989 | ||
| First degree AVB | 0.529 (0.066, 4.223) | .548 | ||
| Second degree AVB | 0.000 | .999 | ||
| RBBB | 1.589 (0.647, 3.903) | .313 | ||
| Ventricular premature beats | 1.560 (0.314, 7.735) | .587 | ||
| Abnormal Q‐wave and poor R‐wave progression | 2.188 (0.744, 6.436) | .155 | ||
| Left ventricular high voltage or hypertrophy | 0.254 (0.033, 1.938) | .186 |
Abbreviation: AVB, atrioventricular block.
We also found that ST‐T abnormal changes were the most common ECG manifestations in COVID‐19 patients, and they accounted for the highest proportion of ECG abnormalities in both critically severe and severe types. The proportion of ST‐T abnormal changes in critically severe type was significantly higher than that in severe type. ST‐T change may be related to hypocalcemia, coronary heart disease, hypertension, or myocardial damage caused by SARS‐CoV‐2. Our study also showed that elevated cTnI and NT‐proBNP levels were the independent risk factors of ST‐T changes. Chen et al (Chen et al., 2020) found that about 20% of COVID‐19 patients may have myocardial damage and cardiac dysfunction. Wang et al. (Dawei et al., 2020) suggested that SARS‐CoV‐2 infection caused myocardial injury, which was mainly manifested in the increase of myocardial injury marker cTnI or cardiac troponin T beyond the 99th percentile upper limit and a potential increase in NT‐ProBNP levels, without clinical evidence of myocardial ischemia (Chaolin et al., 2020). In our study, 23.2% patients with COVID‐19 had increased cTnI and 47.6% had increased NT‐proBNP. And the percentage of elevated cTnI and NT‐proBNP in critically severe type was higher than that in severe type, indicating that more critically ill patients suffer from myocardia damage. For the lack of ECG before onset, it is not yet demonstrated that ST‐T changes are the characteristic finding on ECG of COVID patients. But ST‐T abnormal changes are still important in the diagnosis of myocardia damage and the severity of COVID‐19 patients.
In our study, sinus tachycardia was the second most frequent abnormal ECG change in critically ill patients and the incidence rate was higher than that in severe type, which may be related to fever, hypoxia, myocardial injury, and cardiac insufficiency. However, according to clinical observations (Zhe et al., 2020), COVID‐19 patients with myocardial injury often show sinus tachycardia, especially tachycardia at night, and the acceleration of heart rate that is not commensurate with the increase of body temperature (>10 beats/°C). Some researchers also analyzed the patient's blood oxygen saturation and found that the blood oxygen saturation levels of severe patients are low, but the heart rates are consistent with other groups (Nanshan et al., 2020), showing that COVID‐19 critically ill patients with sinus tachycardia are not always caused by fever and hypoxia. Our study also found that the proportion of patients with increased cTnI and NT‐proBNP in the critically ill group was significantly higher than that of noncritical group, suggesting that a higher proportion of patients in the critically severe group could develop myocardial injury and cardiac insufficiency. Thus, sinus tachycardia is an important ECG feature in the diagnosis of myocardia injury and cardiac insufficiency.
There was statistical significance on atrial fibrillation between critically severe and sever types of COVID‐19 patients. And atrial fibrillation was also with high proportion in abnormal ECG changes, which may be attributed to the lung damage caused by the extensive invasion of SARS‐CoV‐2 to the lungs, or other related damages, such as cardiac insufficiency. The univariate logistic regression analysis showed that elevated cTnI and NT‐proBNP levels, stroke, critically ill, and age were related to atrial fibrillation of COVID‐19 patients. Multivariate logistic regression analysis showed that elevated NT‐proBNP and age were the independent risk factors of atrial fibrillation. It is well known that the incidence of atrial fibrillation increases with age. Our results suggested that cardiac insufficiency plays an important role in the occurrence of atrial fibrillation.
In our study, sinus tachycardia and atrial fibrillation were the independent risk factors of in‐hospital death and ventilator use. As described above, tachycardia and atrial fibrillation were related to cardiac insufficiency and myocardia injury, which indicated that cardiac insufficiency and myocardia injury might be the main reason of death and ventilator use of COVID‐19 patients. And the results further illustrated ECG examination is with great significance in predicting outcomes.
This study is still lacking the dynamic observation and analysis of the ECG of COVID‐19 patients and has no ECG data of patients before admission. Thus, it remains to be verified further whether these ECG changes we found are the characteristic ECG changes in COVID‐19 patients.
5. CONCLUSION
ST‐T changes, sinus tachycardia, and atrial fibrillation are powerful ECG features for diagnosing the severity, myocardia injury, and cardiac insufficiency of COVID‐19 patients. A dynamic observation of changes in ECG can provide an important basis for assessing the severity of COVID‐19 patients.
CONFLICT OF INTEREST
None.
AUTHOR CONTRIBUTIONS
Yina Wang participated in article writing, modification, data acquisition and statistical analysis; Lie Chen participated in article writing, modification, data acquisition and statistical analysis; Jingyi Wang participated in data acquisition and statistical analysis; Xingwei He participated in data acquisition and statistical analysis; Fen Huang participated in paper modification; Jing Chen participated in paper modification; Xiaoyun Yang participated in thesis topic selection, modification, finalization, data analysis.
Wang Y, Chen L, Wang J, et al. Electrocardiogram analysis of patients with different types of COVID‐19. Ann Noninvasive Electrocardiol. 2020;25:e12806 10.1111/anec.12806
Yina Wang and Lie Chen are with equal contributions.
Funding information
This work was supported by grant from the Science and Technology Plan, science and technology department of Hubei Province, 2017ACB644 201710‐201912.
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- Borys, S. , Rory, C. , Barbara, J. D. , Leonard, S. G. , James, J. B. , Anton, G. , … Heart Rhythm Society (2009). AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part Ⅲ: Intraventricular conduction disturbances: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society [J]. Journal of the American College of Cardiology, 53(11), 976–981. 10.1016/j.jacc.2008.12.013 [DOI] [PubMed] [Google Scholar]
- Chaolin, H. , Yeming, W. , Xingwang, L. , Lili, R. , Jianping, Z. , Yi, H. , … Bin, C. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J]. Lancet, 395(10223), 497–506. 10.1016/S0140-6736(20)30183-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen, C. , Chen, C. , Jiangtao, Y. , Ning, Z. , Jiangping, Z. , & Daowen, W. (2020). Analysis of myocardial injury in patients with COVID‐19 and association between concomitant cardiovascular diseases and severity of COVID‐19 [J/OL]. Chinese Journal of Cardiology, 48(0), E008 10.3760/cma.j.cn112148-20200225-00123. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
- Dawei, W. , Bo, H. , Chang, H. , Fangfang, Z. , Xing, L. , Jing, Z. , … Hui, X. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China. JAMA, 323(11), 1061–1069. 10.1001/jama.2020.1585 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elissa, D. , Mahesh, V. M. , Behnood, B. , Taylor, C. , Justin, L. , Giuseppe, B. Z. , … Sahil, A. P. (2020). Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID‐19) pandemic. Journal of the American College of Cardiology, 75(18), 2352–2371. 10.1016/j.jacc.2020.03.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Galen, S. W. , Peter, M. , Hein, W. , Mark, J. , Anton, G. , David, M. M. , … Heart Rhythm Society (2009). AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part Ⅵ: Acute ischemia/infarction: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Journal of the American College of Cardiology, 53(11), 1003–1011. 10.1016/j.jacc.2008.12.016 [DOI] [PubMed] [Google Scholar]
- Hongde, H. , Fenglian, M. , Xin, W. , & Yuan, F. (2020). Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. European Heart Journal, 10.1093/eurheartj/ehaa190. [epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jay, M. S. , William, H. , Leonard, S. G. , James, J. B. , Rory, C. , Barbara, J. D. , … Heart Rhythm Society (2007). AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part Ⅱ: Electrocardiography Diagnostic Statement List: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Journal of the American College of Cardiology, 49, 1128 10.1016/j.jacc.2007.01.025 [DOI] [PubMed] [Google Scholar]
- Nanshan, C. , Min, Z. , Xuan, D. , Jieming, Q. , Fengyun, G. , Yangyun, G. , & Li, Z. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395(10223), 507–513. 10.1016/S0140-6736(20)30211-30327 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paul, K. , Leonard, S. G. , James, J. B. , Rory, C. , Barbara, J. D. , William, E. H. , … Hein, W. (2007). AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part Ⅰ: The electrocardiogram and its technology: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Journal of the American College of Cardiology, 49(10), 1109–1127. 10.1016/j.jacc.2007.01.024 [DOI] [PubMed] [Google Scholar]
- Pentti, M. R. , Borys, S. , Leonard, S. G. , James, J. B. , Rory, C. , Barbara, J. D. , … Heart Rhythm Society (2009). AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part Ⅳ: The ST segment, T and U waves, and the QT interval: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society [J]. Journal of the American College of Cardiology, 53(11), 982–991. 10.1016/j.jacc.2008.12.014 [DOI] [PubMed] [Google Scholar]
- William, H. , Barbara, J. D. , David, M. M. , Peter, O. , Paul, K. , Leonard, S. G. , … Heart Rhythm Society (2009). AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part Ⅴ: Electrocardiogram changes associated with cardiac chamber hypertrophy: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society [J]. Journal of the American College of Cardiology, 53(11), 992–1002. 10.1016/j.jacc.2008.12.015 [DOI] [PubMed] [Google Scholar]
- World Health Organization (2020). Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. Revised from https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. [Google Scholar]
- Zhe, X. , Lei, S. , Yijin, W. , Jiyuan, Z. , Lei, H. , Chao, Z. , … Fu‐Sheng, W. (2020). Pathological findings of COVID‐19 associated with acute respiratory distress syndrome [J/OL]. The Lancet Respiratory Medicine, 8(4), 420–422. 10.1016/S2213-2600(20)30076-X [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.